​

Funding Round

Series B - Swift Biosciences

Series B - Swift Biosciences

Investment Firm

Overview

Swift Biosciences develops molecular biology reagents for research and diagnostic applications.

Announced Date

Oct 17, 2013

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Fletcher Spaght, Inc.

Fletcher Spaght, Inc.

Fletcher Spaght, Inc. is a debt and early_stage_venture and late_stage_venture firm.

Participant Investors

3

Investor Name
Participant InvestorDFJ Mercury
Participant InvestorFletcher Spaght, Inc.
Participant InvestorRenaissance Venture Capital

Round Details and Background

Swift Biosciences raised $7000000 on 2013-10-17 in Series B

Swift Biosciences develops molecular biology reagents for research and diagnostic applications.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 10, 2015
Venture Round - Swift Biosciences
-1.5M
Oct 17, 2013
Series B - Swift Biosciences
3-7.0M
Feb 13, 2012
Venture Round - Swift Biosciences
-500.0K
Aug 19, 2010
Series A - Swift Biosciences
1-3.0M

Recent Activity

There is no recent news or activity for this profile.